首页> 外国专利> Crystalline polymorphs of kinase inhibitor compounds, pharmaceutical compositions containing the same, methods for their production and applications

Crystalline polymorphs of kinase inhibitor compounds, pharmaceutical compositions containing the same, methods for their production and applications

机译:激酶抑制剂化合物的结晶多晶型物,含有该结晶多晶型物的药物组合物,其生产和应用方法

摘要

The present invention discloses crystalline polymorphs of the compounds of formula I, pharmaceutical compositions containing them, and their preparation and application. The compound of formula I of the present invention is as shown in formula I, and its crystal form is crystal form 1, crystal form 2, crystal form 3, crystal form 5, crystal form 6 or crystal form 7. The crystal form stability and chemical stability of each crystal form of the compound of formula I of the present invention is good, and the purity reduction of the chemical stability main component is less than 2%. Each of the crystalline forms of the compound of formula I with high purity can be produced by the production method of the present invention, and the formulation method is suitable for large-scale production. [Chemical 1]
机译:本发明公开了式I化合物的结晶多晶型物,含有它们的药物组合物,以及它们的制备和应用。本发明的式I化合物如式I所示,其晶形为晶形1,晶形2,晶形3,晶形5,晶形6或晶形7。本发明式I化合物的每种晶形的化学稳定性均良好,并且化学稳定性主成分的纯度降低小于2%。可以通过本发明的制备方法制备高纯度的式I化合物的每种结晶形式,并且该配制方法适合于大规模制备。 [化学1]

著录项

  • 公开/公告号JP2019529568A

    专利类型

  • 公开/公告日2019-10-17

    原文格式PDF

  • 申请/专利号JP20190538551

  • 发明设计人 梁従新;謝利華;

    申请日2017-09-29

  • 分类号C07D403/14;A61K31/404;A61P1;A61P13/12;A61P35;A61P43;A61K9/48;A61K47/02;A61K47/20;A61K47/38;A61K47/26;A61K9/20;A61K47/12;A61K47/32;A61K47/04;A61K47/14;

  • 国家 JP

  • 入库时间 2022-08-21 12:23:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号